Status:
COMPLETED
Evaluation of Introcan Safety 3 Closed IV Catheter
Lead Sponsor:
B. Braun Melsungen AG
Conditions:
Patients in Need for Intravenous Access
Eligibility:
All Genders
Brief Summary
Incidence and time of occurrence of blood leakage with the closed intravascular catheter Introcan Safety 3 in comparison to Introcan Safety
Eligibility Criteria
Inclusion
- need for intravenous access
Exclusion
- n. a.
Key Trial Info
Start Date :
September 1 2012
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2012
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT02197013
Start Date
September 1 2012
End Date
October 1 2012
Last Update
August 3 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KKRN Katholisches Klinikum Ruhrgebiet Nord GmbH (KKRN)
Dorsten, Germany